Log In
Sign Up
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
nature.com
Post by
|
3 points
|
Apr 8, 2024
|
Add Comment
About
FAQ
Legal
Contact
© 2023-24 DxMultiomics. All rights reserved.
